PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
Hauptverfasser: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Veröffentlicht: |
2009
|
Search Result 1
PHASE I TRIAL OF A HIGHLY IMMUNOGENIC T-CELL VACCINE FOR HEPATITIS C VIRUS BASED ON NOVEL ADENOVIRAL VECTORS FROM RARE SEROTYPES
Veröffentlicht 2009
Conference item